Clinical trials
Recruiting Phase 2 Diabetic Nephropathies trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ain Shams University | 1 |
| Aptabio Therapeutics, Inc. | 1 |
| Brigham and Women's Hospital | 1 |
| Chinese PLA General Hospital | 1 |
| Medical University of South Carolina | 1 |
| Regeneron Pharmaceuticals | 1 |
| River 3 Renal Corp. | 1 |
| University of Washington | 1 |
| Walden Biosciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetic Nephropathies | 9 |
| Diabetes Mellitus | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Diabetes Mellitus, Type 1 | 1 |
| Glomerulonephritis, IGA | 1 |
| Kidney Diseases | 1 |
| Nephrosis, Lipoid | 1 |
| Renal Insufficiency | 1 |
| Renal Insufficiency, Chronic | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.